Paul Samuel Gaynon MD

Pediatric Hematology & Oncology•Los Angeles, CA

Professor, Pediatrics, USC School of Medicine

Join to View Full Profile

4650 W Sunset BlvdLos Angeles, CA 90027
Phone+1 323-361-2163
Fax+1 323-361-7128

Education & Training

Stanford Health Care-Sponsored Stanford UniversityResidency, Pediatrics, 1974 - 1976
University of Illinois College of MedicineClass of 1974
Boston Children’s Hospital/Boston Medical CenterFellowship, Pediatric Hematology/Oncology

Certifications & Licensure

CA State Medical License 1998 - 2026
WI State Medical License 1987 - 1999
IL State Medical License 1976 - 1990
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

Super Doctor SuperDoctors.com

Clinical Trials

Combination Chemotherapy With or Without Donor Bone Marrow Transplantation in Treating Infants With Previously Untreated Acute Lymphoblastic Leukemia Start of enrollment: 2002 Nov 01
Completed
Phase 2
ABT-751 With Chemotherapy for Relapsed Pediatric ALL Start of enrollment: 2006 May 22
Terminated
Phase 1, Phase 2
Erwinase for Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) (IND 104224) Start of enrollment: 2009 Apr 13
Terminated
Phase 1
T2007-002 Clofarabine, Etoposide, Cyclophosphamide in Relapsed Acute Myelogenous Leukemia (AML) Start of enrollment: 2009 Jul 10
Terminated
Phase 2
Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL Start of enrollment: 2010 Jun 01
Terminated
Phase 1, Phase 2
A Study Of Panobinostat In Children With Refractory Hematologic Malignancies Start of enrollment: 2011 Mar 01
Completed
Phase 1
A Pilot Study of Decitabine and Vorinostat With Chemotherapy for Relapsed ALL Start of enrollment: 2011 Dec 01
Terminated
Phase 1, Phase 2
A Phase 1 Dose Escalation and Expanded Cohort Study of EPZ-5676 in the Treatment of Pediatric Patients With Relapsed/Refractory Leukemias Bearing a Rearrangement of the MLL Gene Start of enrollment: 2014 May 01
Completed
Phase 1
Join now to see all

Publications & Presentations

PubMed

Clinical Relapse Versus Treatment Failure: The Case for Surveillance for Re-Appearance of Minimal Measurable Disease in Pediatric Patients with Higher Risk B-ALL.
Paul S Gaynon, Linwei Li
Pediatric Blood & Cancer. 2025-01-01
Development of second genetically distinct T-lymphoblastic leukemia in a pediatric patient.
Haley Hultquist, Alyssa Rodriguez, Juanita E Ferreira, Juanita E Ferreira, Alexandra Placek
Pediatric Blood & Cancer. 2024-08-01
Efficacy and safety of FLAG-IDA as front-line therapy in de novo paediatric acute myeloid leukaemia population.
Andrew Doan, Holly K T Huang, Ari J Hadar, Jemily Malvar, Teresa Rushing
British Journal of Haematology. 2023-07-01

Grant Support

Clinical Trial: ABT-751 Combined With Dexamethasone, Peg-Asparaginase, And DoxorNational Center For Research Resources2009
Childrens Cancer GroupNational Cancer Institute1998–2002
Childrens Cancer GroupNational Cancer Institute1997
Childrens CancerNational Cancer Institute1994–1996
Children'S Cancer Study GroupNational Cancer Institute1989–1993